Cantor Fitzgerald downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Buy to Hold.

For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.

Shares of Salix Pharmaceuticals closed at $155.76 yesterday.